Found 39 Small Cell Lung Cancer trials
A listing of Small Cell Lung Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Sort by:
This study investigates the use of investigational medications in combination with pembrolizumab, with or without chemotherapy, for people with Stage IV non-small cell lung cancer (NSCLC). The purpose of this study is to evaluate the safety and effectiveness of these treatment combinations in participants who have not previously received treatment …
This study investigates the effect of adding stereotactic body radiation therapy (SBRT) to the usual treatment for patients with locally advanced non-small cell lung cancer (NSCLC) that cannot be treated with surgery. The purpose is to see if SBRT, which uses precise radiation to target tumors, can improve outcomes when …
This is an investigator-initiated, open label phase Ib study examining 2nd line atezolizumab and tocilizumab in a cohort of recurrent/metastatic non-small cell lung cancer patients who have received prior immune checkpoint inhibitor therapy with or without other forms of therapy (i.e. chemotherapy, radiation). Patients with driver mutations in EGFR, ALK, …
This study compares the impact of using a combination of drugs, ramucirumab and pembrolizumab, versus standard chemotherapy for treating advanced non-small cell lung cancer that is stage IV or recurrent. Ramucirumab blocks new blood vessel growth that tumors need, while pembrolizumab boosts the immune system to fight cancer. The trial …
This study investigates non-squamous non-small cell lung cancer. It focuses on patients with advanced or metastatic forms of this condition who have previously been treated and do not have actionable genomic alterations.The study evaluates the effectiveness and tolerability of an investigational medication compared to standard care. It also involves an …
The purpose of this study is to investigate the effect of adding an investigational medication to the immunotherapy drug durvalumab in patients with non-small cell lung cancer (NSCLC) who have undergone chemotherapy and surgery. The study aims to see if the combination of treatments can increase the time patients remain …
This study investigates non-small cell lung cancer (NSCLC).The study evaluates the effectiveness of an investigational drug compared to a standard treatment for NSCLC.Who can participate: Participants must have locally advanced or metastatic non-small cell lung cancer with high PD-L1 expression.Study details: Participants will receive either the investigational medication or a …
This study investigates high-risk stage I non-small cell lung cancer. The purpose of this study is to evaluate treatment options for patients who have had their cancer completely removed through surgery.The study focuses on evaluating the safety and effectiveness of different treatment options for preventing cancer recurrence. It assesses the …
This study investigates the safety, tolerability, and preliminary effectiveness of an investigational medication, either alone or in combination with another treatment, for patients with advanced solid tumors. The study includes patients with specific types of cancer, such as urothelial cancer and non-small cell lung cancer, who have not responded to …
This study investigates the treatment of KRAS-mutated cancers. The purpose of this study is to evaluate the safety and preliminary effectiveness of a new investigational treatment in patients with specific types of cancer that have a KRAS mutation.The study focuses on assessing the safety and how well the investigational treatment …
Please choose between Voice or SMS based delivery of verification code
or